Personalized Dendritic Cell Vaccination Safe, but More Research Needed on Efficacy
Source: AJMC, October 2021
Melanoma patients with metastatic disease face low survival rates despite the advent of immunotherapies, which have changed the way many cancers, including melanoma, are treated.
